TrialHIV medicine2015

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

J D Baxter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.